Results 11 to 20 of about 116,699 (313)

Conduction System Pacing Versus Conventional Cardiac Resynchronization Therapy in Congenital Heart Disease [PDF]

open access: greenJACC: Clinical Electrophysiology, 2022
Dyssynchrony-associated left ventricular systolic dysfunction is a major contributor to heart failure in congenital heart disease (CHD). Although conventional cardiac resynchronization therapy (CRT) has shown benefit, the comparative efficacy of cardiac conduction system pacing (CSP) is unknown.The purpose of this study was compare the clinical ...
Jeremy P. Moore   +21 more
openalex   +4 more sources

Rare SCN10A variants associated with cardiac conduction system diseases [PDF]

open access: bronzeEuropean Heart Journal, 2020
Abstract Background The genetic bases of cardiac conduction-system disease (CCSD) range from ion channelopathies to mutations in many other genes. Genome-wide association studies have shown common variants in SCN10A influence cardiac conduction.
Kenshi Hayashi   +10 more
openalex   +2 more sources

Rapidly Progressive Cardiac Manifestation of Behçet's Disease Involving Conduction System and Aortic Valve [PDF]

open access: hybridJournal of Cardiovascular Ultrasound, 2011
Cardiac conduction system impairment is a rare clinical manifestation of Behçet's disease. We report a patient who showed 1st degree atrioventricular block at first presentation, and showed aggravated finding of 3rd degree atrioventricular block on five months later.
Jin Yu   +9 more
openalex   +4 more sources

Cardiac Hypertrophy, Accessory Pathway, and Conduction System Disease in an Adolescent

open access: greenJournal of the American College of Cardiology, 2013
We present the case of PRKAG2 cardiac syndrome, a rare autosomal-dominant genetic disease characterized by peculiar clinical and electrophysiological abnormalities. We clearly show through the images the peculiar clinical features that should raise suspicion of a mutant PRKAG2 gene. Indeed, together with an accurate clinical and instrumental evaluation,
Enrico Fabris   +9 more
  +7 more sources

Limited effects of long-term enzyme replacement therapy on the cardiac conduction system in Fabry disease [PDF]

open access: bronzeJournal of Cardiology Cases, 2018
The long-term effects of enzyme replacement therapy (ERT) on cardiac function and the conduction system in Fabry disease are not clearly understood. We report a case of a 48-year-old man with non-classical Fabry disease treated with ERT for 11 years.
Tomoya Kaneda   +10 more
openalex   +3 more sources

A HISTOPATHOLOGICAL STUDY ON THE CONDUCTION SYSTEM OF THE SO-CALLED "POKKURI DISEASE" : SUDDENUNEXPECTED CARDIAC DEATH OF UNKNOWN ORIGIN IN JAPAN

open access: bronzeJapanese Circulation Journal, 1976
The conduction system of seven cases died of the so-called "Pokkuri disease", was histopathologically studied with serial sectioning method. Fibrosis with a significant reduction of conduction fibers was observed in the sinoartrial node and junction between the node and atrial muscle fibers in 6 cases.
Koh Gotoh
  +6 more sources

Home - About - Disclaimer - Privacy